Industry engagement

To build the mRNA industry in Victoria, mRNA Victoria collaborates with partners across the ecosystem including research institutes, start-ups, venture capitalists, industry bodies and established industry players.

Australian Centre for AI in Medical Innovation (ACAMI)

mRNA Victoria has partnered with La Trobe University to launch the Australian Centre for AI in Medical Innovation, ACAMI.

ACAMI brings together world-leading experts in artificial intelligence and medical research to change the way we diagnose and treat cancer, infectious diseases, and cardiovascular disease.

Researchers at the centre will use artificial intelligence to advance medical research, develop workforce capabilities and improve clinical trials – uncovering new treatments, vaccines and immunotherapies for cancers, diseases and viruses.

Combining La Trobe’s artificial intelligence researchers with existing medical research capabilities, ACAMI works with collaboration partners like the Olivia Newton John Cancer Research Centre to develop new diagnostic tools and treatment options for patients.

BioMelbourne Network

mRNA Victoria has partnered with BioMelbourne Network to deliver a sold-out series of mRNA lectures to the local industry.

Topics covered in the lecture series includes the Future Potential of the mRNA Platform, Clinical Trials, and how mRNA technology can better prepare the global community for a future pandemic.

Recordings of mRNA Victoria’s lectures can be found on the BioMelbourne Network website.

mRNA Victoria actively participates in local industry events and conferences

mRNA Victoria is actively participating in local industry events and conferences, including AusBioTech, Advances in mRNA Science, and the Australian Vaccine Value Chain Conference.

Through our Research Grant Programs, mRNA Victoria is supporting local researchers and biotech startups to commercialise their research breakthroughs to progress from the pre-clinical stage to the clinical trial stage and become the next generation of mRNA vaccines and therapies.

Our team is always keen to hear from investors, start-ups, established biotech companies, and venture capital firms from both Australia and overseas to discuss opportunities to partner with our mRNA ecosystem.

For more information about mRNA Victoria and our investment, please contact us via email mRNAvictoria@ecodev.vic.gov.au or follow us on LinkedIn.